{"id":34906,"date":"2009-07-27T00:00:00","date_gmt":"2009-07-27T05:00:00","guid":{"rendered":"https:\/\/www.unmc.edu\/newsroom\/2009\/07\/27\/seminar-on-nibib-funding-today-at-noon\/"},"modified":"2009-07-27T00:00:00","modified_gmt":"2009-07-27T05:00:00","slug":"seminar-on-nibib-funding-today-at-noon","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/newsroom\/2009\/07\/27\/seminar-on-nibib-funding-today-at-noon\/","title":{"rendered":"Seminar on NIBIB funding today at noon"},"content":{"rendered":"


\n
\n
\n

\n\"picture
\n<\/TD>
\n<\/TR>
\n

\n
\nBelinda Seto, Ph.D.
\n<\/FONT>
\n<\/TD>
\n<\/TR>
\n<\/TABLE>Belinda Seto, Ph.D., deputy director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB), will present “Funding Opportunities” today at noon in the Durham Research Center Auditorium. <\/p>\n

UNeMed<\/a>, the technology transfer leader for UNMC, will sponsor the event. <\/p>\n

NIBIB is the principal institute at the National Institute of Health with the primary mission of funding and conducting research and training that bridge the physical and life sciences. <\/p>\n

Its research portfolio is broadly inclusive of the development of medical technologies and their applications in clinical settings. With a budget of $308 million in fiscal year 2009, the NIBIB has invested strategically in technologies to improve early diagnosis of diseases, treatment at the point of care when patients are diagnosed and molecular imaging to monitor treatment efficacy. <\/p>\n

Technologies include:
\n